EPICONCEPT

Their core work

EpiConcept is a Paris-based epidemiology consultancy specializing in vaccine effectiveness monitoring, infectious disease surveillance, and pandemic preparedness across Europe. They design and coordinate multi-country epidemiological studies, pooling data from primary care and hospital networks to evaluate vaccines and track respiratory diseases. Their work directly supports public health decision-making by providing real-world evidence on vaccine performance and building preparedness frameworks for pandemic response.

What they specialise in

How they've shifted over time

EpiConcept began with a focused mandate on influenza vaccine effectiveness monitoring through the I-MOVE-plus platform (2015-2018), building a European-wide infrastructure for pooling clinical data. When COVID-19 emerged, they pivoted this exact infrastructure to address the pandemic — I-MOVE-COVID-19 (2020-2022) expanded their scope to include multidisciplinary virological surveillance, hospital networks, and treatment evaluation. Their most recent involvement in PANDEM-2 signals a broadening from pure epidemiology into pandemic preparedness technology and crisis response planning.

EpiConcept is moving from disease-specific vaccine monitoring toward broader pandemic preparedness systems that combine epidemiology with information technology and crisis response planning.

How they like to work

EpiConcept predominantly leads projects — they coordinated 2 of their 3 H2020 projects, indicating strong project management capability and an established reputation as a trusted lead partner. With 59 unique consortium partners across 20 countries, they operate as a network hub, likely because their work requires pooling data from clinical sites and public health institutes across many European countries. This makes them an attractive coordinator for any project needing pan-European health data collection infrastructure.

EpiConcept has built an extensive network of 59 partners across 20 countries, reflecting the pan-European nature of vaccine and disease surveillance work that requires data collection points distributed widely across the continent.

What sets them apart

EpiConcept occupies a rare niche as a private epidemiology SME that can coordinate large European surveillance networks — a role typically filled by public health agencies or universities. Their continuity from I-MOVE-plus through I-MOVE-COVID-19 demonstrates an operational platform that survived a real-world stress test during the pandemic. For consortium builders, they bring both the scientific methodology and the ready-made data collection network across 20 countries.

Highlights from their portfolio

• I-MOVE-plus
  Their flagship project (EUR 1.6M as coordinator) — built the European platform for measuring vaccine effectiveness that later proved critical during COVID-19.
• I-MOVE-COVID-19
  Rapid-response project that repurposed the I-MOVE infrastructure for COVID-19, demonstrating the real-world value of their surveillance network during a global crisis.
• PANDEM-2
  Marks their expansion beyond epidemiology into pandemic preparedness technology, including simulation and IT-based response planning.